Matched-Comparative Modeling of Normal and Diseased Human Airway Responses Using a Microengineered Breathing Lung Chip

Cell Syst. 2016 Nov 23;3(5):456-466.e4. doi: 10.1016/j.cels.2016.10.003. Epub 2016 Oct 27.

Abstract

Smoking represents a major risk factor for chronic obstructive pulmonary disease (COPD), but it is difficult to characterize smoke-induced injury responses under physiological breathing conditions in humans due to patient-to-patient variability. Here, we show that a small airway-on-a-chip device lined by living human bronchiolar epithelium from normal or COPD patients can be connected to an instrument that "breathes" whole cigarette smoke in and out of the chips to study smoke-induced pathophysiology in vitro. This technology enables true matched comparisons of biological responses by culturing cells from the same individual with or without smoke exposure. These studies led to identification of ciliary micropathologies, COPD-specific molecular signatures, and epithelial responses to smoke generated by electronic cigarettes. The smoking airway-on-a-chip represents a tool to study normal and disease-specific responses of the human lung to inhaled smoke across molecular, cellular and tissue-level responses in an organ-relevant context.

Keywords: biomarker; cell culture; cigarette smoke; cilia; cytokine; electronic cigarette; human study; lung airway; microfluidic; organ chip; transcriptomic analysis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Electronic Nicotine Delivery Systems
  • Epithelial Cells
  • Humans
  • Lung*
  • Pulmonary Disease, Chronic Obstructive
  • Respiration
  • Smoking